West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 5.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,207 shares of the medical instruments supplier’s stock after selling 517 shares during the quarter. Mutual of America Capital Management LLC’s holdings in West Pharmaceutical Services were worth $3,033,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in WST. UBS Group AG lifted its holdings in shares of West Pharmaceutical Services by 15.8% during the fourth quarter. UBS Group AG now owns 82,290 shares of the medical instruments supplier’s stock worth $28,976,000 after purchasing an additional 11,245 shares during the period. Assetmark Inc. raised its holdings in shares of West Pharmaceutical Services by 40.4% during the fourth quarter. Assetmark Inc. now owns 3,650 shares of the medical instruments supplier’s stock worth $1,285,000 after purchasing an additional 1,050 shares during the last quarter. Commerce Bank lifted its position in West Pharmaceutical Services by 6.3% during the fourth quarter. Commerce Bank now owns 10,863 shares of the medical instruments supplier’s stock valued at $3,825,000 after purchasing an additional 640 shares during the period. Hsbc Holdings PLC boosted its holdings in West Pharmaceutical Services by 39.8% in the fourth quarter. Hsbc Holdings PLC now owns 138,468 shares of the medical instruments supplier’s stock valued at $48,750,000 after purchasing an additional 39,392 shares during the last quarter. Finally, Artisan Partners Limited Partnership grew its position in West Pharmaceutical Services by 23.2% during the 4th quarter. Artisan Partners Limited Partnership now owns 1,961,063 shares of the medical instruments supplier’s stock worth $690,530,000 after purchasing an additional 369,792 shares during the period. Hedge funds and other institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Stock Performance

Shares of WST stock opened at $306.73 on Tuesday. West Pharmaceutical Services, Inc. has a 52-week low of $265.00 and a 52-week high of $413.70. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03. The stock has a market cap of $22.34 billion, a PE ratio of 40.47, a price-to-earnings-growth ratio of 10.58 and a beta of 1.01. The business has a 50-day simple moving average of $303.10 and a 200-day simple moving average of $336.80.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm had revenue of $702.10 million during the quarter, compared to analyst estimates of $729.36 million. During the same quarter in the prior year, the firm earned $2.11 earnings per share. The business’s revenue for the quarter was down 6.9% on a year-over-year basis. On average, equities analysts expect that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

Insider Activity at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the transaction, the vice president now owns 1,478 shares in the company, valued at $443,400. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.53% of the stock is owned by company insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.